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We report an outbreak of botulism that occurred in July
2002 in a group of 12 Alaskan Yu’pik Eskimos who ate
blubber and skin from a beached beluga whale. Botulism
death rates among Alaska Natives have declined in the last
20 years, yet incidence has increased. 
T
he incidence of botulism in Alaska is among the high-
est in the world, and all cases of foodborne botulism in
Alaska have been associated with eating traditional Alaska
Native foods, including “fermented” foods, dried foods,
seal oil, and muktuk (skin and a thin pinkish blubber layer
immediately underneath the skin) from marine mammals
(1,2). Botulism toxins are divided into seven types; intox-
ication with toxin type E is exclusively associated with eat-
ing aquatic animals. Most cases of botulism in Alaska are
caused by toxin type E. 
On July 12, 2002, two residents of a Yup’ik village in
western Alaska found a carcass of a beached beluga whale
that appeared to have died sometime that spring. They col-
lected the tail fluke for consumption, cut it into pieces, and
put the pieces in sealable plastic bags. Portions were
refrigerated and distributed to family and friends. From
July 13 to July 15, a total of 14 persons ate some of the raw
muktuk. On July 17, a physician from western Alaska
reported three suspected cases of botulism from this vil-
lage; all patients had eaten the muktuk. The Alaska
Department of Health and Social Services began an imme-
diate investigation to ensure proper treatment of the ill per-
sons, identify and interview other persons exposed to the
implicated food, and obtain clinical and food samples for
laboratory testing.
The Study
We sought to identify and interview every person who
ate the muktuk; all exposed persons identified were evalu-
ated by a physician or nurse practitioner for signs or symp-
toms of botulism. Exposed persons with signs or
symptoms compatible with foodborne botulism were
referred to the regional hospital for further evaluation and
treatment, if necessary. A case of foodborne botulism was
defined as a clinically compatible illness (Figure) with
symmetric descending flaccid paralysis of motor and auto-
nomic nerves in a person who had eaten the muktuk.
Serum, stool, and gastric specimens from case-patients and
leftover muktuk were collected and submitted to the
Centers for Disease Control and Prevention (CDC)
National Botulism Surveillance and Reference Laboratory
for botulinum toxin detection, using the standard mouse
bioassay (1). 
Of 14 persons identified who ate the muktuk, 8 (57%)
had illness that met the case definition. Three of the eight
patients were male; the median age was 73 years (range
13–83 years). The median incubation period was 24 hours
(range 12–72 hours). Signs and symptoms are shown in the
Table. Five (63%) patients were hospitalized, four (50%)
received types AB and E antitoxin a median of 30 hours
(range 24–60 hours) after symptom onset, two (25%)
required mechanical ventilation, and all survived. Both
persons who required mechanical ventilation received
antitoxin. Attending clinicians decided not to give antitox-
in to four of the patients with milder illness because of the
potential risk for adverse side effects from horse serum
antitoxin.
Three stool, three gastric fluid, and seven serum sam-
ples from the eight patients and seven samples of whale
muktuk were tested for botulinum toxin. The mean sample
collection interval for serum was 3 days after exposure
(range 1–5 days); for stool and gastric fluid, the mean
interval was 4 days after exposure (range 3–6 days). The
diagnostic laboratory received all laboratory specimens on
July 26, and results were reported on August 1. Type E
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Figure. Clinical and laboratory findings of foodborne botulism.
*Centers for Disease Control and Prevention, Atlanta, Georgia,
USA; †United States Department of Agriculture, Fort Collins,
Colorado, USA; and ‡Alaska Department of Health and Social
Services, Anchorage, Alaska, USAtoxin was detected in a stool sample from one patient. This
stool sample was collected on day 5 after exposure and
received for testing 7 days later. All other clinical speci-
mens were negative for botulinum toxin. All seven sam-
ples of muktuk were positive for type E botulinum toxin. 
Conclusions
An outbreak of botulism type E affected 8 of 14 Alaska
Natives who ate muktuk harvested from a dead beached
whale found on the remote Alaska Bering Sea littoral.
Illness was promptly diagnosed and antitoxin adminis-
tered. Although the median serum, stool, and gastric fluid
sample collection times were within 4 days of illness
onset, and all muktuk samples tested positive for toxin
type E, only 1 of the 13 clinical samples from case-patients
yielded positive results for toxin with the standard mouse
bioassay. Both the limited sensitivity of the mouse bioas-
say for botulinum toxin detection in clinical specimens, as
seen in this outbreak, and the fact that the test requires up
to 4 days for final results demonstrate that clinicians
should not wait for laboratory confirmation to make diag-
nostic and clinical treatment decisions. 
Almost half of the cases of all types of foodborne bot-
ulism in the United States occur in Alaska, which has 0.2%
of the national population. From 1990 to 2000, a total of 97
cases of botulism type E were reported in the United
States; 91 (92%) occurred in Alaska. Alaska Native death
rates from botulism have dropped during recent decades.
Arctic explorers and whalers described deaths of entire
Alaska Native families who ate whale meat (3). Before
1961, the botulism case-fatality rate among Alaska Natives
was nearly 50%; from 1967 to 1974, it declined to 9% (4).
From 1990 to 2000, the case-fatality rate averaged 3%,
lower than that of the other 49 states. This reduction is due
to several factors. First, public health efforts have educat-
ed the population and clinicians serving it about preven-
tion, signs, symptoms, and the need for immediate
treatment of botulism. Second, immediate evacuation of
rural patients to modern regional hospitals, often by small
aircraft, is routinely practiced. Third, trivalent botulinum
antitoxin (anti-A, B, and E) is stocked in most rural hospi-
tals so it is immediately available for treatment when clin-
ically indicated (5).
Type E toxin is responsible for >85% of all botulism
cases in Alaska because many traditional Alaska Native
foods, including salmon heads, whale blubber, seal flesh
and oil, and fish eggs are prepared by fermentation under
conditions that may favor germination and vegetation of
toxin type E–producing Clostridium botulinum (4,6).
Eating blubber from whale carcasses as described in this
outbreak is in accordance with tradition; however, storing
blubber in airtight sealable plastic bags, which can create
an anaerobic environment, is a modern development. The
use of airtight containers to store and ferment traditional
foods is theorized to be at least partly responsible for the
increase in incidence of foodborne botulism in Alaska
from 1970 to 1997 (5). 
In his 1963 review of botulism type E, Dolman suggest-
ed a logical solution to the problem of botulism in the Arctic
when he stated that “Public health educational efforts based
on a proper understanding of the dangers involved can do
much to reduce them by advocating relevant sanitary pre-
cautions. Besides, merely drawing attention to these haz-
ards will accelerate the march of acculturation and thus
eventually render [traditional Alaska Native foods] unpop-
ular (6).” Since that time, however, anthropologic and pale-
ontologic studies have found negative health effects
associated with rapid cultural transformation (7), and stud-
ies have found that rapid changes from subsistence diets to
affluent (Western) diets have been associated with
increased incidence of coronary heart disease, obesity, dia-
betes mellitus, and cancer among Alaska Natives (8–11). In
addition, eating traditional foods can form part of the cul-
tural identity of groups that are in cultural transition and
therefore may be perpetuated as a link to the past (2). To
that end, state and federal public health officials have
invested considerable effort in promoting intake of tradi-
tional foods among Alaska Natives, while defining safer
methods for food storage and preparation (5,12).
DISPATCHES
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Table. Signs and symptoms of eight case-patients from a 
botulism outbreak associated with eating a beached whale, 
western Alaska, July 2002 
Sequelae No.  (%) 
Gastrointestinal symptoms    
Abdominal pain  5 (63) 
Constipation 5  (63) 
Diarrhea 4  (50) 
Nausea or vomiting  7 (88) 
Neurologic symptoms    
Blurred vision  5 (63) 
Diplopia 1  (13) 
Dry mouth  7 (88) 
Dysphagia 6  (75) 
Dysarthria 4  (50) 
Shortness of breath  5 (63) 
Other symptoms   
Throat pain  3 (38) 
Dizziness 6  (75) 
Neurologic signs   
Hoarse voice  5 (63) 
Ptosis 2  (25) 
Pupils fixed and dilated  5 (63) 
Urinary retention  1 (13) 
Weakness 8  (100) 
Other signs   
Bradycardia
a 4 (50) 
Hypotension
b 6 (75) 
aHeart rate <60 beats per minute. 
bSystolic blood pressure <100 mm Hg. Because botulism may have nonspecific symptoms
(e.g., abdominal cramping, diarrhea, vomiting), rapid diag-
nosis can be difficult, even in Alaska, where the index of
suspicion is comparatively elevated. However, some spe-
cific signs and symptoms (e.g., descending paralysis) may
be detectable early on and are virtually diagnostic (Figure).
The clinical signs and symptoms of botulism from toxin
types A, B, and E are similar; however, a clinical compar-
ison in the United States from 1975 to 1988 showed that
patients with illness from type E toxin have slightly short-
er incubation periods and less frequently required intuba-
tion (39% with type E, 52% with type B, and 67% with
type A) (13). Additional current reports on botulism,
including the epidemiology, diagnosis, therapy, outbreak
response, and reference laboratories have been recently
published (1,14). 
In conclusion, clinicians confronted with a suspected
botulism case should review the clinical diagnostic criteria
and not rely on the mouse bioassay for toxin detection to
guide clinical decision-making. In addition, although pub-
lic health efforts and clinical improvements have drastical-
ly reduced botulism death rates among Alaska Natives, the
average annual incidence of foodborne botulism in Alaska
since 1970 is substantially higher than it was before 1970,
possibly, in part, because of modern influences, such as
availability of plastic, sealable containers. Finally, because
of the numerous beneficial health (not to mention cultural)
effects of traditional food consumption, we recommend
that Alaska Native leaders continue to promote traditional
food consumption among their people, while educating
them about the potential hazards of improper storage and
preparation (12). 
Dr. McLaughlin is a medical epidemiologist with the Alaska
Section of Epidemiology. His epidemiologic interests include
infectious disease epidemiology, coronary heart disease among
Alaska Natives, and electronic disease reporting surveillance
systems.
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